Latest News
13-Jan-2025 Pharma Lobby Seeks 2-year Extension of Schedule M Deadline
07-Jan-2025 Biosimilar Brand Buy to Help Intas Take on Biggies
07-Jan-2025 Biosimilar Brand Buy to Help Intas Take on Biggies
01-Jan-2025 Erring Drug Cos to Face Stricter Action Under Schedule M
01-Jan-2025 ‘PE Interest Shows Potential of Healthcare Sector’
  more...
Latest Reports
Jan-25 US pricing pressure eases; margins improve - Nirmal Bang  
Jan-25 Chemicals/Pharma EXIM trends - Phillip Capital  
Jan-25 3QFY25 Preview: Change in script unlikely - Emkay Research  
Jan-25 Bed additions/ARPOB to drive growth during the quarter - Centrum Research  
Jan-25 US/India to drive Pharma; Volume-led growth to continue for Diagnostics - Centrum Research  
  more...

Quarterly Summary September-2024
Desc Current Previous Per.Chg
Sales 67242.7 61013.1 10.2
Otherincome 2488.6 2287.7 8.8
Expense 49904.7 47193.7 5.7
RawMaterial 19003.4 18996.8 0.0
StaffCost 9916.5 9105.9 8.9
ExciseDuty 78.8 58.9 33.9
OtherExp 15371.3 14258.0 7.8
Interest 1058.2 1028.8 2.9
GrossProfit 20070.8 16023.1 25.3
Depreciation 2672.0 2717.1 -1.7
Tax 4076.5 2892.1 41.0
NetProfit 13339.3 10504.1 27.0
Total.Comp 176 -- --
Source: ETIG Database

Sectoral Companies As on 15 Jan 2025
Company Name (Top 10) MarketCap (Rs.Crore)
Sun Pharma. 421521.02
Divi's Lab 156026.20
Cipla 116851.64
Dr.Reddy's 111742.85
Torrent Phar 108779.69
Mankind Phar 107086.20
Zydus Life 99090.58
Lupin 97096.84
Aurobindo Ph 67223.24
Alkem Labora 62177.36
Abbott (I) 58998.39
Glenmark Pha 41680.94
IPCA Lab. 39715.47
  click here for the complete list